re: CSL for ALPHA Alpha,
The analyst review and the subsequent price action is interesting, 'Merrill lowered its net profit forecast for CSL's current financial year by 4.6 per cent to $124.4 million. The new estimate is in line with CSL's own forecast of between $120 million and $125 million' !!
and yet the price the price is half its January peak!
Can somebody post the complete report or email the report to me. I'm interested to ascertain if the analyst took into account the IVIG improved inventory situation. Which apparently was of concern in the first half.
What is PE based on today’s price and 2003 earnings estimate? Somewhere in the 20's I'd imagine by now.
AS you can tell, I have faith in this company. The only concern I have is, being the 5th largest company in its segment, the potential predatory action by their bigger competitors at today’s market cap!
I believe the back page of the Fin Review had an interesting article on CSL.
First the dot bombs, then the bio busts, what next? The gold cold?
Good investing.
re: CSL for ALPHA Alpha,The analyst review and the subsequent...
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$308.02 |
Change
0.160(0.05%) |
Mkt cap ! $148.8B | |||
| Open | High | Low | Value | Volume |
| $307.95 | $310.00 | $306.26 | $190.3M | 617.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 1111 | $307.95 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $308.30 | 350 | 1 |
View Market Depth
| Last trade - 16.10pm 17/07/2024 (20 minute delay) ? |
| CSL (ASX) Chart |